clinical trial · NCT00076973
An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)
Organon and Co·phase3·completed·n = 1,125
Bronchiolitismontelukast sodiumComparator: placebo
brief summary
The purpose of this study is to look at whether an investigational drug can treat the breathing symptoms of RSV bronchiolitis in children 3 to 24 months of age.
started
Aug 1, 2003
primary completion
Jun 1, 2006
completion
Oct 1, 2006
last updated
Aug 15, 2024
official title
A Randomized, 2-Period, Multicenter, Dble-Blind, Parallel-Group Study Comparing Effects of 2 Doses of MK0476 and Placebo in the Tx of Respiratory Symptoms Associated w/ Respiratory Syncytial Virus-Induced Bronchiolitis in Children 3 to 24 Mths
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol